Vimian Group AB (publ) (VIMGF)
OTCMKTS
· Delayed Price · Currency is USD
3.500
-0.385 (-9.91%)
At close: Dec 30, 2024
Vimian Group AB Revenue
Vimian Group AB had revenue of 87.65M EUR in the quarter ending September 30, 2024, with 9.72% growth. This brings the company's revenue in the last twelve months to 352.39M, up 8.52% year-over-year. In the year 2023, Vimian Group AB had annual revenue of 331.73M with 17.92% growth.
Revenue (ttm)
352.39M EUR
Revenue Growth
+8.52%
P/S Ratio
n/a
Revenue / Employee
320.36K EUR
Employees
1,100
Market Cap
1.89B USD
Revenue Chart
* This company reports financials in EUR.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Endo Inc. | 1.79B |
| SS Innovations International | 16.04M |
| Veradigm | 1.53B |
| Elite Pharmaceuticals | 71.17M |
| Glass House Brands | 188.29M |
| Northwest Biotherapeutics | 1.60M |
| BioStem Technologies | 210.49M |
| Silence Therapeutics | 21.77M |